Cargando…

Inverting hydrolases and their use in enantioconvergent biotransformations

Owing to the more abundant occurrence of racemic compounds compared to prochiral or meso forms, most enantiomerically pure products are obtained via racemate resolution. This review summarizes (chemo)enzymatic enantioconvergent processes based on the use of hydrolytic enzymes, which are able to inve...

Descripción completa

Detalles Bibliográficos
Autores principales: Schober, Markus, Faber, Kurt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science Publishers 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3725421/
https://www.ncbi.nlm.nih.gov/pubmed/23809848
http://dx.doi.org/10.1016/j.tibtech.2013.05.005
_version_ 1782476789674672128
author Schober, Markus
Faber, Kurt
author_facet Schober, Markus
Faber, Kurt
author_sort Schober, Markus
collection PubMed
description Owing to the more abundant occurrence of racemic compounds compared to prochiral or meso forms, most enantiomerically pure products are obtained via racemate resolution. This review summarizes (chemo)enzymatic enantioconvergent processes based on the use of hydrolytic enzymes, which are able to invert a stereocenter during catalysis that can overcome the 50%-yield limitation of kinetic resolution. Recent developments are presented in the fields of inverting or retaining sulfatases, epoxide hydrolases and dehalogenases, which allow the production of secondary alcohols or vicinal diols at a 100% theoretical yield from a racemate via enantioconvergent processes.
format Online
Article
Text
id pubmed-3725421
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Elsevier Science Publishers
record_format MEDLINE/PubMed
spelling pubmed-37254212013-08-01 Inverting hydrolases and their use in enantioconvergent biotransformations Schober, Markus Faber, Kurt Trends Biotechnol Review Owing to the more abundant occurrence of racemic compounds compared to prochiral or meso forms, most enantiomerically pure products are obtained via racemate resolution. This review summarizes (chemo)enzymatic enantioconvergent processes based on the use of hydrolytic enzymes, which are able to invert a stereocenter during catalysis that can overcome the 50%-yield limitation of kinetic resolution. Recent developments are presented in the fields of inverting or retaining sulfatases, epoxide hydrolases and dehalogenases, which allow the production of secondary alcohols or vicinal diols at a 100% theoretical yield from a racemate via enantioconvergent processes. Elsevier Science Publishers 2013-08 /pmc/articles/PMC3725421/ /pubmed/23809848 http://dx.doi.org/10.1016/j.tibtech.2013.05.005 Text en © 2013 Elsevier Ltd. https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/) , which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use.
spellingShingle Review
Schober, Markus
Faber, Kurt
Inverting hydrolases and their use in enantioconvergent biotransformations
title Inverting hydrolases and their use in enantioconvergent biotransformations
title_full Inverting hydrolases and their use in enantioconvergent biotransformations
title_fullStr Inverting hydrolases and their use in enantioconvergent biotransformations
title_full_unstemmed Inverting hydrolases and their use in enantioconvergent biotransformations
title_short Inverting hydrolases and their use in enantioconvergent biotransformations
title_sort inverting hydrolases and their use in enantioconvergent biotransformations
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3725421/
https://www.ncbi.nlm.nih.gov/pubmed/23809848
http://dx.doi.org/10.1016/j.tibtech.2013.05.005
work_keys_str_mv AT schobermarkus invertinghydrolasesandtheiruseinenantioconvergentbiotransformations
AT faberkurt invertinghydrolasesandtheiruseinenantioconvergentbiotransformations